BRIEF published on 10/26/2026 at 07:10, 19 days 17 hours ago TME Pharma prolonge l'échéance de sa dette pour améliorer sa visibilité financière Valeur Actionnariale Stabilité Financière Échéance De La Dette Financement Par Obligations Licence NOX-A12
BRIEF published on 10/26/2026 at 07:10, 19 days 17 hours ago TME Pharma Extends Debt Maturity to Enhance Financial Visibility Shareholder Value Debt Maturity Financial Stability Bond Financing NOX-A12 Licensing
PRESS RELEASE published on 10/26/2026 at 07:05, 19 days 17 hours ago TME Pharma améliore sa visibilité financière en prolongeant l'échéance de sa dette jusqu'en juin 2028
PRESS RELEASE published on 10/26/2026 at 07:05, 19 days 17 hours ago TME Pharma extends financial visibility by lengthening debt maturity to June 2028
BRIEF published on 09/16/2026 at 08:05, 1 month 28 days ago TME Pharma NV's strategy and financial commitment Biotechnology Partnerships Financial Strategy TME Pharma NOX-A12
BRIEF published on 09/16/2026 at 08:05, 1 month 28 days ago Stratégie et engagement financier de TME Pharma N.V. Biotechnologie Stratégie Financière Partenariats TME Pharma NOX-A12
PRESS RELEASE published on 09/16/2026 at 08:00, 1 month 28 days ago MESSAGE DU CEO DE TME PHARMA TME Pharma publie une lettre aux actionnaires du CEO. Détails sur la stratégie financière, les partenariats pour le NOX-A12, la gestion du capital et les activités futures Stratégie Financière Partenariats CEO TME Pharma NOX-A12
PRESS RELEASE published on 09/16/2026 at 08:00, 1 month 28 days ago TME PHARMA CEO MESSAGE TME Pharma CEO message emphasizes strategic approach, financial discipline, and long-term value creation for shareholders. Updates on NOX-A12, cost-reduction strategy, and future plans CEO Message Financial Discipline TME Pharma Strategic Approach NOX-A12
BRIEF published on 08/24/2026 at 08:10, 2 months 21 days ago TME Pharma Advances Toward Strategic Partnerships for Cancer Therapy Glioblastoma NOX-A12 Licensing Partnerships Biotech Market Trends CEO Share Transaction
BRIEF published on 08/24/2026 at 08:10, 2 months 21 days ago TME Pharma progresse vers des partenariats stratégiques pour la thérapie du cancer Glioblastome NOX-A12 Partenariats De Licence Tendances Du Marché Des Biotechnologies Transaction D'actions Du PDG
Published on 11/14/2026 at 12:56, 11 hours 26 minutes ago Gabriel Announces Dismissal of ICSID Annulment Application
Published on 11/14/2026 at 01:30, 22 hours 52 minutes ago NuRAN Wireless Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published on 11/14/2026 at 00:40, 23 hours 42 minutes ago BEACN Announces Annual General and Special Meeting Results
Published on 11/14/2026 at 00:35, 23 hours 47 minutes ago American Hotel Income Properties REIT LP Reports Q3 2026 Results
Published on 11/14/2026 at 00:00, 1 day ago SLAM Announces Proposed Extension of Warrant Expiry Dates
Published on 11/13/2026 at 23:24, 1 day ago EQS-Adhoc: ASOS PLC: Repurchase of £90m of 2028 Convertible Bonds
Published on 11/13/2026 at 21:52, 1 day 2 hours ago EQS-Adhoc: Airbus reports share buyback transactions 9-13 November 2026
Published on 11/13/2026 at 19:08, 1 day 5 hours ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026
Published on 11/13/2026 at 19:00, 1 day 5 hours ago Assemblée générale ordinaire des actionnaires le 18 décembre 2026
Published on 11/13/2026 at 11:35, 1 day 12 hours ago ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/13/2026 at 11:35, 1 day 12 hours ago ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France
Published on 11/13/2026 at 08:00, 1 day 16 hours ago Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 2 days 1 hour ago Belgrano continues the implementation of its public share buyback offer (OPRA)
